Diagnosis, Treatment, and Prognosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Adults

Nerra Dahl, a renowned professor at Mayo Clinic and director of the Polycystic Kidney Disease Foundation Center of Excellence, dives into the complexities of Autosomal Dominant Polycystic Kidney Disease (ADPKD). She discusses the genetic underpinnings of the disease and its impact on kidney function, emphasizing the importance of genetic testing for effective diagnosis. The conversation also highlights innovative treatments like Tolvaptan, the significance of monitoring intracranial aneurysms, and promising advances in kidney transplantation outcomes for ADPKD patients.